Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,877,000)	$ (4,610,000)	$ (2,836,000)	$ 1,681,000	$ (11,284,000)	$ (6,577,000)	$ (16,100,000)
Adjustments to reconcile net loss to cash used in operating activities:
Change in fair value of common stock warrant and option liabilities	(1,880,000)		(4,777,000)		(1,880,000)	(4,601,000)
Change in fair value of contingent consideration	(0)		(0)		(70,000)	(140,000)
Issuance and offering costs	314,000		0		314,000	769,000
Depreciation					354,000	737,000
Amortization of intangible assets					39,000	99,000
Lease amortization					686,000	914,000
Impairment of intangible assets	0		120,000		72,000	120,000	3,300,000
(Gain) loss on disposal of property and equipment	0		0		(386,000)	17,000
Stock-based compensation	314,000		354,000		897,000	1,035,000
Bad debt expense					32,000	0
Realized gain on corporate securities					0	(10,222,000)
Impairment of property and equipment					370,000	1,319,000
Write-down of inventory	15,000		818,000		1,530,000	1,802,000
Gain on extinguishment of PPP loan	0		(1,123,000)		0	(1,123,000)
Gain on sale of Verdeca	0		0		(1,138,000)	0
Changes in operating assets and liabilities:
Accounts receivable					(534,000)	(47,000)
Inventories					1,071,000	(2,651,000)
Prepaid expenses and other current assets					(90,000)	(452,000)
Other noncurrent assets					15,000	(159,000)
Accounts payable and accrued expenses					(890,000)	972,000
Amounts due to related parties					(17,000)	(29,000)
Unearned revenue					0	(8,000)
Other current liabilities					6,000	1,000
Operating lease liabilities					(718,000)	(984,000)
Net cash used in operating activities					(11,621,000)	(19,208,000)	(25,900,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property and equipment	5,000				897,000	2,000
Proceeds from sale of Verdeca - earn-out received					285,000
Purchases of property and equipment					(46,000)	(919,000)
Acquisitions, net of cash acquired					0	(4,250,000)
Proceeds from sales and maturities of investments					0	21,845,000
Net cash provided by (used in) investing activities					1,136,000	16,678,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the exercise of warrants					0	22,000
Principal payments on debt						(2,032,000)
Proceeds from ESPP purchases					7,000	39,000
Capital contributions received from non-controlling interest					0	750,000
Net cash provided by financing activities					4,519,000	22,014,000
Effects of foreign currency translation on cash and cash equivalents					(0)	(1,000)
Net (decrease) increase in cash and cash equivalents					(5,966,000)	19,483,000
Cash and cash equivalents - beginning of period		$ 28,685,000		$ 16,043,000	28,685,000	16,043,000	16,043,000
Cash and cash equivalents - end of period	$ 22,719,000		$ 35,526,000		22,719,000	35,526,000	$ 28,685,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes						1,000
Cash paid for interest					1,000	25,000
NONCASH INVESTING AND FINANCING ACTIVITIES:
Shares of common stock issued at closing of Arcadia Wellness transaction					0	2,053,000
Right of use assets obtained in exchange for new operating lease liabilities					114,000	1,662,000
Proceeds from sale of Verdeca in accounts and other receivable					854,000	0
August 2022 Offering [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock pre-funded warrants and preferred investment options					5,000,000	0
Payments of offering costs					(488,000)	0
January 2021 PIPE Purchase Agreement [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants from offering					0	25,147,000
Payments of offering costs					0	(1,912,000)
NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock warrants issued to placement agent and included in offering costs related to purchase agreement					0	942,000
August 2022 RDO Securities Purchase Agreement [Member]
NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock options issued to placement agent and included in offering costs					191,000	0
Accounting Standards Update 2020-06 [Member]
NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock warrant liabilities reclassified to equity					$ 3,392,000	$ 0